These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28844804)

  • 1. DAT SPECT may have diagnostic value in prodromal SCA2 patients with parkinsonism.
    Miyaue N; Tada S; Ando R; Iwaki H; Yabe H; Nishikawa N; Nagai M; Takashima H; Nomoto M
    Parkinsonism Relat Disord; 2017 Nov; 44():137-141. PubMed ID: 28844804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
    Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
    Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism.
    Varrone A; Salvatore E; De Michele G; Barone P; Sansone V; Pellecchia MT; Castaldo I; Coppola G; Brunetti A; Salvatore M; Pappatà S; Filla A
    Ann Neurol; 2004 Mar; 55(3):426-30. PubMed ID: 14991822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism.
    Kim JM; Hong S; Kim GP; Choi YJ; Kim YK; Park SS; Kim SE; Jeon BS
    Arch Neurol; 2007 Oct; 64(10):1510-8. PubMed ID: 17923635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study.
    Boesch SM; Donnemiller E; Müller J; Seppi K; Weirich-Schwaiger H; Poewe W; Wenning GK
    Mov Disord; 2004 Nov; 19(11):1320-5. PubMed ID: 15390003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
    Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SCA6 presenting parkinsonism without ataxia--A case report].
    Takeshima S; Takeda I; Kobatake K; Yamashita T; Abe K; Kuriyama M
    Rinsho Shinkeigaku; 2015; 55(4):243-7. PubMed ID: 25904253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of combining
    Niimi Y; Ito S; Murate K; Hirota S; Hikichi C; Ishikawa T; Maeda T; Nagao R; Shima S; Mizutani Y; Ueda A; Mutoh T
    J Neurol Sci; 2017 Jun; 377():174-178. PubMed ID: 28477690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of dopamine transporter imaging (DAT-SPECT) and
    Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
    J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.
    Tachibana K; Matsuura K; Shindo A; Matsuyama H; Ii Y; Taniguchi A; Tomimoto H
    Intern Med; 2020; 59(4):485-490. PubMed ID: 32062624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
    Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism in SCA19/22: Dopamine Transporter Imaging in an Italian Family Harboring a Novel Mutation.
    Contaldi E; Gallo S; Corrado L; D'Alfonso S; Magistrelli L
    Cerebellum; 2024 Jun; 23(3):1226-1230. PubMed ID: 37857779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders.
    Akdemir ÜÖ; Bora Tokçaer A; Atay LÖ
    Turk J Med Sci; 2021 Apr; 51(2):400-410. PubMed ID: 33237660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
    Furtado S; Payami H; Lockhart PJ; Hanson M; Nutt JG; Singleton AA; Singleton A; Bower J; Utti RJ; Bird TD; de la Fuente-Fernandez R; Tsuboi Y; Klimek ML; Suchowersky O; Hardy J; Calne DB; Wszolek ZK; Farrer M; Gwinn-Hardy K; Stoessl AJ
    Mov Disord; 2004 Jun; 19(6):622-9. PubMed ID: 15197699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonism in Spinocerebellar ataxia type 7.
    Lee D; Na BS; Hong IK; Ahn TB
    J Neurol Sci; 2016 Jun; 365():151-3. PubMed ID: 27206895
    [No Abstract]   [Full Text] [Related]  

  • 18. Referral practice, reporting standards, and the impact of dopamine transporter scans done in a tertiary hospital.
    Bhattacharjee S; Chalissery AJ; Barry T; O'Sullivan D; O'Connell M; Lynch T
    Neurol India; 2017; 65(6):1264-1270. PubMed ID: 29133699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dopamine transporter SPECT in patients with Parkinson's disease].
    Hamano T; Tsuchida T; Hirayama M; Fujiyama J; Mutoh T; Yonekura Y; Kuriyama M
    Kaku Igaku; 2000 Mar; 37(2):125-9. PubMed ID: 10783572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism.
    Gaig C; Martí MJ; Tolosa E; Valldeoriola F; Paredes P; Lomeña FJ; Nakamae F
    Mov Disord; 2006 Nov; 21(11):1994-8. PubMed ID: 16941463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.